|
|
|
Contemporary Oncology is dedicated to improving patient care through the publication of peer-reviewed, clinical articles that have practical application for today’s oncologists. More info...
CLICK HERE FOR CURRENT ISSUE |
|
| |
|
|
|
Editorial: Highlights from Two Key Symposiums Reporting on new research and emerging trends in breast and liver cancer. |
| |
Beyond Genetics: Emerging Breakthroughs in Breast Cancer Battle Key findings from the 2008 ASCO Breast Cancer conference; updates on goserelin, capecitabine, docetaxel & lapatinib. |
| |
Highlights of 2nd Annual ILCA Conference Cutting-edge treatments for hepatocellular carcinoma, including contrast-enhanced ultrasound, combined CRT/TACE, sorafenib, & LCCRT for patients with PVT. |
| |
Anti–Lung Cancer Compound ASA404 Progresses to Phase III A pivotal phase III study is currently underway to evaluate the efficacy and safety of Novartis’ novel anti-cancer compound ASA404 in patients with non–small cell lung cancer (NSCLC). |
| |
Flu Vaccination in Patients with Cancer During the 2006–2007 season, influenza
circulated at epidemic levels for about 14
weeks and peaked during February, the month
most frequently associated with peak activity
over the past 31 influenza seasons. |
| |
Metastatic Breast Cancer Worldwide: Different Languages, Different Views, Different Goals Breast cancer in general is not openly discussed in Malaysia, but this may be changing. |
| |
|
|